Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 108,179 | 85,772 | 88,049 | 83,407 | 76,181 |
| Cost of Goods | 56,372 | 44,089 | 45,893 | 43,161 | 38,094 |
| Gross Profit | 51,807 | 41,683 | 42,156 | 40,246 | 38,087 |
| Operating Expenses | 41,961 | 33,717 | 34,570 | 30,874 | 29,491 |
| Operating Income | 10,218 | 8,055 | 8,479 | 9,533 | 8,690 |
| Interest Expense | 677 | 277 | 389 | 365 | 429 |
| Other Income | 22 | 2,034 | -440 | 400 | 135 |
| Pre-tax Income | 9,563 | 9,812 | 7,650 | 9,568 | 8,396 |
| Income Tax | -9,452 | 2,673 | 2,240 | 1,970 | 1,775 |
| Net Income Continuous | 19,015 | 7,139 | 5,410 | 7,598 | 6,621 |
| Net Income Discontinuous | 0 | 94 | -3,737 | -8,952 | -8,962 |
| Net Income | $19,015 | $7,233 | $1,673 | $-1,354 | $-2,341 |
| EPS Basic Total Ops | 6.60 | 2.40 | 0.50 | -0.40 | -0.80 |
| EPS Basic Continuous Ops | 6.60 | 2.40 | 1.80 | 2.50 | 2.20 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | -1.20 | -2.90 | -2.90 |
| EPS Diluted Total Ops | 6.50 | 2.40 | 0.50 | -0.40 | -0.80 |
| EPS Diluted Continuous Ops | 6.50 | 2.40 | 1.70 | 2.40 | 2.10 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | -1.20 | -2.90 | -2.90 |
| EBITDA(a) | $14,224 | $11,507 | $11,846 | $13,007 | $12,027 |